Roy S, Martel J, Ma S, Tenenhouse H S
Department of Biology, McGill University-Montreal Children's Hospital Research Institute, Quebec, Canada.
Endocrinology. 1994 Apr;134(4):1761-7. doi: 10.1210/endo.134.4.8137741.
X-Linked Hyp mice exhibit rachitic bone disease, hypophosphatemia, impaired renal phosphate reabsorption, and abnormal regulation of renal 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism. We demonstrated that phosphate deprivation of Hyp mice, but not normal littermates, elicits a dramatic fall in serum 1,25-(OH)2D levels and an increase in renal 1,25-(OH)2D3 catabolism that can be ascribed to an increase in the activity of renal mitochondrial 25-hydroxyvitamin D3-24-hydroxylase (24-hydroxylase), the first enzyme in the C-24 oxidation pathway. The present study was undertaken to elucidate the mechanism for the increase in renal 24-hydroxylase activity in phosphate-deprived Hyp mice. Phosphate deprivation of Hyp mice resulted in a 3-fold increase in the maximum velocity for 24-hydroxylase (n = 5; P < 0.001) accompanied by an increase in 24-hydroxylase immunoreactive protein relative to the level of ornithine aminotransferase. Phosphate deprivation of Hyp mice also elicited a 3-fold increase in renal 24-hydroxylase mRNA abundance relative to that of beta-actin mRNA (n = 7; P < 0.001). The increase in 24-hydroxylase mRNA was specific to the kidney and was evident as early as 1 day of the low phosphate diet. Phosphate deprivation had no effect on renal 24-hydroxylase immunoreactive protein or mRNA in normal littermates. In contrast to the abnormal 24-hydroxylase response to dietary phosphate, Hyp mice exhibited an appropriate increase in renal 24-hydroxylase mRNA and catalytic activity in response to increasing doses of 1,25-(OH)2D3. The present results demonstrate that elevated renal 24-hydroxylase activity in phosphate-deprived Hyp mice can be ascribed to an increase in the abundance of 24-hydroxylase mRNA and protein and suggest that inappropriate regulation of 1,25-(OH)2D3 catabolism in Hyp mice occurs at the pretranslational level.
X连锁低磷血症小鼠表现出佝偻病性骨病、低磷血症、肾磷酸盐重吸收受损以及肾1,25 - 二羟基维生素D3 [1,25-(OH)2D3]代谢的异常调节。我们证明,低磷血症小鼠而非正常同窝小鼠的磷酸盐缺乏会引发血清1,25-(OH)2D水平急剧下降以及肾1,25-(OH)2D3分解代谢增加,这可归因于肾线粒体25 - 羟基维生素D3 - 24 - 羟化酶(24 - 羟化酶)活性增加,该酶是C - 24氧化途径中的首个酶。本研究旨在阐明磷酸盐缺乏的低磷血症小鼠肾24 - 羟化酶活性增加的机制。低磷血症小鼠的磷酸盐缺乏导致24 - 羟化酶的最大反应速度增加了3倍(n = 5;P < 0.001),同时相对于鸟氨酸氨基转移酶水平,24 - 羟化酶免疫反应性蛋白增加。低磷血症小鼠的磷酸盐缺乏还导致肾24 - 羟化酶mRNA丰度相对于β - 肌动蛋白mRNA增加了3倍(n = 7;P < 0.001)。24 - 羟化酶mRNA的增加在肾脏中具有特异性,早在低磷饮食的第1天就很明显。磷酸盐缺乏对正常同窝小鼠的肾24 - 羟化酶免疫反应性蛋白或mRNA没有影响。与对饮食磷酸盐的异常24 - 羟化酶反应相反,低磷血症小鼠对增加剂量的1,25-(OH)2D3表现出肾24 - 羟化酶mRNA和催化活性的适当增加。目前的结果表明,磷酸盐缺乏的低磷血症小鼠肾24 - 羟化酶活性升高可归因于24 - 羟化酶mRNA和蛋白丰度的增加,并表明低磷血症小鼠中1,25-(OH)2D3分解代谢的不适当调节发生在翻译前水平。